Cellular and molecular determinants of limited anti-tumor immunity in chromophobe renal carcinoma (ChRCC).
Chris Labaki(Beth Israel Deaconess Medical Center), David A. Braun(Yale Cancer Center), Ziad Bakouny(Dana-Farber Cancer Institute), Sayed Matar(Brigham and Women's Hospital), Charbel Hobeika(Brigham and Women's Hospital), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Nicholas Schindler(Yale Cancer Center), Sabina Signoretti(Brigham and Women's Hospital), Renée Maria Saliby(Yale University), Toni K. Choueiri(Harvard University), Damir Khabibullin(Brigham and Women's Hospital), Nourhan El Ahmar(Brigham and Women's Hospital), Kevin Bi(Broad Institute), Elizabeth P. Henske(Brigham and Women's Hospital), Sachet A. Shukla(The University of Texas MD Anderson Cancer Center), Carmen Priolo(Brigham and Women's Hospital), Sabrina Y. Camp(Dana-Farber Cancer Institute), Michel Alchoueiry(Brigham and Women's Hospital), Long Zhang(Zhejiang Cancer Hospital), Eddy Saad(Dana-Farber Cancer Institute)
Cited by 1
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
|Cell|2015|4.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k